AAAAAA

   
Results: 1-13 |
Results: 13
MYCOBACTERIUM SZULGAI OSTEOMYELITIS IN AN AIDS PATIENT
Authors: LUQUE AE KAMINSKI D REICHMAN R HARDY D
Citation: Ae. Luque et al., MYCOBACTERIUM SZULGAI OSTEOMYELITIS IN AN AIDS PATIENT, Scandinavian journal of infectious diseases, 30(1), 1998, pp. 88-91
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF DEPRENYL AND THIOCTIC ACID IN HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED COGNITIVE IMPAIRMENT
Authors: SACKTOR N KIEBURTZ K SCHIFITTO G MCDERMOTT M BOURGEOIS K PALUMBO D ORME C ZIMMERMAN C GELBARD H HICKEY C CASACELI C GUTHRIE B RUMFOLA L PLUMB S RUDOLPH A KAMP C EPSTEIN L MARDER K ALBERT S DOONEIEF G STERN Y TODAK G FRIEDMANCLOUSE R POLANCO C WINSTON T MAYEUX R SACKTOR N SELNES O HASENAUER D ESPOSITO D NANCESPROSON L MCARTHUR J OSULLIVAN J SHOULSON I OAKES D REICHMAN R
Citation: N. Sacktor et al., A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF DEPRENYL AND THIOCTIC ACID IN HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED COGNITIVE IMPAIRMENT, Neurology, 50(3), 1998, pp. 645-651
VARIABILITY AND PROGNOSTIC VALUES OF VIROLOGICAL AND CD4 CELL MEASURES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED PATIENTS WITH 200-500 CD4 CELLS MM(3) (ACTG-175)/
Authors: LATHEY JL HUGHES MD FISCUS SA PI T JACKSON JB RASHEED S ELBEIK T REICHMAN R JAPOUR A DAQUILA RT SCOTT W GRIFFITH BP HAMMER SM KATZENSTEIN DA
Citation: Jl. Lathey et al., VARIABILITY AND PROGNOSTIC VALUES OF VIROLOGICAL AND CD4 CELL MEASURES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED PATIENTS WITH 200-500 CD4 CELLS MM(3) (ACTG-175)/, The Journal of infectious diseases, 177(3), 1998, pp. 617-624
CHANGES IN VIROLOGICAL MARKERS AS PREDICTORS OF CD4 CELL DECLINE AND PROGRESSION OF DISEASE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTEDADULTS TREATED WITH NUCLEOSIDES
Authors: FISCUS SA HUGHES MD LATHEY JL PI T JACKSON JB RASHEED S ELBEIK T REICHMAN R JAPOUR A BYINGTON R SCOTT W GRIFFITH BP KATZENSTEIN DA HAMMER SM
Citation: Sa. Fiscus et al., CHANGES IN VIROLOGICAL MARKERS AS PREDICTORS OF CD4 CELL DECLINE AND PROGRESSION OF DISEASE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTEDADULTS TREATED WITH NUCLEOSIDES, The Journal of infectious diseases, 177(3), 1998, pp. 625-633
SAFETY AND TOLERABILITY OF THE ANTIOXIDANT OPC-14117 IN HIV-ASSOCIATED COGNITIVE IMPAIRMENT
Authors: KIEBURTZ K SCHIFITTO G MCDERMOTT M HEO M IRVINE C PALUMBO D ORME C ZIMMERMAN C GELBARD H HICKEY C CASACELI C GUTHRIE B RUMFOLA L EPSTEIN L MARDER K RAMACHANDRAN G ALBERT S DOONEIEF G STERN Y TODAK G FRIEDMANCLOUSE R POLANCO C WINSTON T MAYEUX R DALPAN G SELNES O SACKTOR N HASENAUER D ESPOSITO D NANCESPROSON L MCARTHUR JC SHOULSON I OAKES D REICHMAN R OSULLIVAN J
Citation: K. Kieburtz et al., SAFETY AND TOLERABILITY OF THE ANTIOXIDANT OPC-14117 IN HIV-ASSOCIATED COGNITIVE IMPAIRMENT, Neurology, 49(1), 1997, pp. 142-146
THE RELATION OF VIROLOGICAL AND IMMUNOLOGICAL MARKERS TO CLINICAL OUTCOMES AFTER NUCLEOSIDE THERAPY IN HIV-INFECTED ADULTS WITH 200 TO 500 CD4 CELLS PER CUBIC MILLIMETER
Authors: KATZENSTEIN DA HAMMER SM HUGHES MD GUNDACKER H JACKSON JB FISCUS S RASHEED S ELBEIK T REICHMAN R JAPOUR A MERIGAN TC HIRSCH MS
Citation: Da. Katzenstein et al., THE RELATION OF VIROLOGICAL AND IMMUNOLOGICAL MARKERS TO CLINICAL OUTCOMES AFTER NUCLEOSIDE THERAPY IN HIV-INFECTED ADULTS WITH 200 TO 500 CD4 CELLS PER CUBIC MILLIMETER, The New England journal of medicine, 335(15), 1996, pp. 1091-1098
PROGNOSTIC VALUE OF PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) RNA LEVELS IN PATIENTS WITH ADVANCED HIV-1 DISEASE AND WITH LITTLE OR NO PRIOR ZIDOVUDINE THERAPY
Authors: WELLES SL JACKSON JB YENLIEBERMAN B DEMETER L JAPOUR AJ SMEATON LM JOHNSON VA KURITZKES DR DAQUILA RT REICHELDERFER PA RICHMAN DD REICHMAN R FISCHL M DOLIN R COOMBS RW KAHN JO MCLAREN C TODD J KWOK S
Citation: Sl. Welles et al., PROGNOSTIC VALUE OF PLASMA HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) RNA LEVELS IN PATIENTS WITH ADVANCED HIV-1 DISEASE AND WITH LITTLE OR NO PRIOR ZIDOVUDINE THERAPY, The Journal of infectious diseases, 174(4), 1996, pp. 696-703
CORRELATION OF PLASMA HIV-1 RNA LEVEL AND DEVELOPMENT OF RESISTANCE MUTATIONS TO AZT AND DDI WITH DISEASE PROGRESSION IN PATIENTS WITH ADVANCED HIV-1 DISEASE AND LITTLE OR NO AZT THERAPY
Authors: CRUMPACKER C WELLES S YENLIEBERMAN B DEMETER L JAPOUR A SMEATON L JOHNSON V KURITZES D DAQUILA R REICHELDERFER P RICHMAN D REICHMAN R MCLAREN C TODD J KWOK S COOMBS R JACKSON B
Citation: C. Crumpacker et al., CORRELATION OF PLASMA HIV-1 RNA LEVEL AND DEVELOPMENT OF RESISTANCE MUTATIONS TO AZT AND DDI WITH DISEASE PROGRESSION IN PATIENTS WITH ADVANCED HIV-1 DISEASE AND LITTLE OR NO AZT THERAPY, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 42-42
DIAGNOSIS OF HERPES-SIMPLEX ENCEPHALITIS - APPLICATION OF POLYMERASE CHAIN-REACTION TO CEREBROSPINAL-FLUID FROM BRAIN-BIOPSIED PATIENTS ANDCORRELATION WITH DISEASE
Authors: LAKEMAN FD WHITLEY RJ ALFORD C COBBS CG MORAWETZ R SOONG S HIRSCH MS DOLAN R BETTS R REICHMAN R COREY L LEVIN M HANDLEY D CONNER J SPECTOR S OXMAN M RICHMAN D HAYDEN F GREENLEE J LINNEMANN C POWELL D DURAK D POLLARD R JONCAS J ARVIN A YEAGER A WRIGHT P EDWARDS C KLEIMAN M FIFE K LIU K HINTHORN D PAZIN G HO M BARINGER R COHEN M LEMON S CHOW A WEIL M TILLES J
Citation: Fd. Lakeman et al., DIAGNOSIS OF HERPES-SIMPLEX ENCEPHALITIS - APPLICATION OF POLYMERASE CHAIN-REACTION TO CEREBROSPINAL-FLUID FROM BRAIN-BIOPSIED PATIENTS ANDCORRELATION WITH DISEASE, The Journal of infectious diseases, 171(4), 1995, pp. 857-863
DIDEOXYNUCLEOSIDE RESISTANCE EMERGES WITH PROLONGED ZIDOVUDINE MONOTHERAPY
Authors: MAYERS DL JAPOUR AJ ARDUINO JM HAMMER SM REICHMAN R WAGNER KF CHUNG R LANE J CRUMPACKER CS MCLEOD GX BECKETT LA ROBERTS CR WINSLOW D BURKE D RUIZ N FUJIMARAJUSTICE M KERNOZEK P KOCH J BREWER C HICKS C SHELLIE ME LORIZLIM L SMALLS C HAMILTON A MCCUTCHAN F SANDERSBUELL E WEISLOW O FOWLER A LANE J MERRITT L
Citation: Dl. Mayers et al., DIDEOXYNUCLEOSIDE RESISTANCE EMERGES WITH PROLONGED ZIDOVUDINE MONOTHERAPY, Antimicrobial agents and chemotherapy, 38(2), 1994, pp. 307-314
TRIMETREXATE WITH LEUCOVORIN VERSUS TRIMETHOPRIM-SULFAMETHOXAZOLE FORMODERATE TO SEVERE EPISODES OF PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH AIDS - A PROSPECTIVE, CONTROLLED MULTICENTER INVESTIGATION OF THE AIDS-CLINICAL-TRIALS-GROUP PROTOCOL-029 031/
Authors: SATTLER FR FRAME P DAVIS R NICHOLS L SHELTON B AKIL B BAUGHMAN R HUGHLETT C WEISS W BOYLEN CT VANDERHORST C BLACK J POWDERLY W STEIGBIGEL RT LEEDOM JM MASUR H FEINBERG J BENOIT S EYSTER E GOCKE D BECK K LEDERMAN M PHAIR J REICHMAN R SACKS HS SOIERO R
Citation: Fr. Sattler et al., TRIMETREXATE WITH LEUCOVORIN VERSUS TRIMETHOPRIM-SULFAMETHOXAZOLE FORMODERATE TO SEVERE EPISODES OF PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH AIDS - A PROSPECTIVE, CONTROLLED MULTICENTER INVESTIGATION OF THE AIDS-CLINICAL-TRIALS-GROUP PROTOCOL-029 031/, The Journal of infectious diseases, 170(1), 1994, pp. 165-172
PERINATAL TRANSMISSION OF AN AZT RESISTANCE MUTATION (AZT-R) FROM A MOTHER TO HER INFANT
Authors: FRENKEL LM DEMETER LM WAGNER L TEJANI NA LAMBERT JS BLUMBERG BM EPSTEIN LG STRUSSENBERG JG REICHMAN R
Citation: Lm. Frenkel et al., PERINATAL TRANSMISSION OF AN AZT RESISTANCE MUTATION (AZT-R) FROM A MOTHER TO HER INFANT, Journal of cellular biochemistry, 1993, pp. 96-96
STANDARDIZED PERIPHERAL-BLOOD MONONUCLEAR CELL-CULTURE ASSAY FOR DETERMINATION OF DRUG SUSCEPTIBILITIES OF CLINICAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES
Authors: JAPOUR AJ MAYERS DL JOHNSON VA KURITZKES DR BECKETT LA ARDUINO JM LANE J BLACK RJ REICHELDERFER PS DAQUILA RT CRUMPACKER CS BALFOUR H ERICE A COOMBS R KATZENSTEIN D LATHEY J RICHMAN D MCINTOSH K RANGAN S REICHMAN R SCOTT W USSERY M ABRAMS L MCCUTCHAN F BURKE D GARDNER L ROBERTS C CHUNG R HICKS C SHELLIE E FOWLER A MERRITT L FUJIMURAJUSTICE M RUIZ N WAGNER K GAIL M
Citation: Aj. Japour et al., STANDARDIZED PERIPHERAL-BLOOD MONONUCLEAR CELL-CULTURE ASSAY FOR DETERMINATION OF DRUG SUSCEPTIBILITIES OF CLINICAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES, Antimicrobial agents and chemotherapy, 37(5), 1993, pp. 1095-1101
Risultati: 1-13 |